Patients included in this study have been followed up at ambulatory centers of the Hemominas Foundation after diagnosis of sickle cell disease. The disease diagnosis were performed by cellular morphological analysis of blood smear, solubility test for hemoglobins using sodium dithionite (Na2S2O4) and hemoglobin electrophoresis in alkaline pH. When the diagnosis was not clear, the following additional tests were performed: sickling test by sodium meta-bisulphite (Na2S2O5) method and hemoglobin electrophoresis in acid pH. All the SCD patients included in this study were homozygous for HbS (SS) or have the HbS allele associated with other abnormal hemoglobin. The distribution of Hb genotypes for SCD was as follow: 68.5% were SS, 18.5% SC, 3.5% S β thal and 0.5% SD. Therefore, 22.5% of the SCD patients were heterozygous for HbS, but most of them were SC, whose both alleles are original from Africa. Only four percent of the patients may have one non-African variant. This distribution suggests that the extensive non-African admixture in SCD Brazilian patients cannot be explained by the inclusion of a high proportion of heterozygous HbS-individuals bearing non-African abnormal variants of Hb. The genotype of SCD was not available for 9% of the patients, but there is no reason to suppose that these individuals had a higher frequency of non-African variants. Therefore, neither the SCD diagnosis nor the distribution of Hb genotypes suggest that the analyzed individuals have a bias toward non-African ancestry that could explain the observed extensive non-African ancestry.
As we explained in the companion paper, the level of admixture of SCD patients has implications for the design of association studies aimed at identifying new genetic modifiers of SCD clinical manifestations, particularly if these outcomes are associated with ancestry. If both genetic variants and clinical manifestations are associated with ancestry, there are two important issues to address. First, an observed association may be spurious if ancestry is not controlled for. Second, the admixture mapping strategy may be used. The risk of spurious association and the power of admixture mapping increase both with the level of admixture. However, estimates of ancestry are rare in SCD patients. Excluding GWASs, association studies between SNPs and SCD sub-phenotypes seldom control for ancestry. For instance, Lettre et al. 9 reported an association between candidate SNPs and HbF levels in a Brazilian cohort of SCD patients, without controlling for ancestry.
Admixture may be estimated at population and at individual levels. In this study, we estimated population admixture by three methods: (1) the method of genetic identity by Chakraborty, 10 as implemented in the software ADMIX95. This method takes into account sampling error of allele frequencies and the effect of the genetic drift since the admixture event on the parental and admixed populations; 11 (2) the method by  Doupanloup and Bertorelle   12 , based on the coalescent theory, that consider sampling error of allele frequencies, the time and the effect of genetic drift since the admixture event on the parental and admixed populations, the degree of divergence of the parental populations at the time of admixture, and possible mutations that occurred after the admixture event. The comparisons by Choisy et al. 13 have shown that these methods works reasonably well under a wide set of evolutionary histories compatibles with the history of human populations. We estimated individual admixture using the Bayesian approach implemented in the software Structure, 14, 15 that assumes that admixed individuals derive from parental populations that are in Hardy-Weinberg equilibrium for each locus and in linkage equilibrium between loci. Structure was run using the following parameters: K=3 (number of parental populations), burn-in Period = 100 000, MCMC cycles after burn-in= 100 000, we used a priori information for the individuals from parental populations to assist the clustering (USEPOPINFO=1), model = ADMIXTURE for the admixed individuals, α parameter was inferred for each population, GENSBACK = 2, MIGRPRIOR = 0.05, correlated allele frequencies. 90% Credibility Intervals were also estimated.
The results from the different admixture estimations point to an extensive admixture in both groups, although a higher African admixture was observed among SCD patients (Table S1 ), as expected. Variations in levels of population admixture between the different regions of Minas Gerais ( Figure S2 ), as well as among individuals sampled in each region ( Figure S3 ), were observed both for patients and blood donors.
The allele frequencies for the studied loci in the blood donors and sickle cell patients are included in the Table S2 and individual genotypes are available under request from the authors. Individuals from parental populations (European, African and Amerindians) are those reported in da Silva et al. 16 Figure S1. Geographic distribution of healthy blood donors and sickle cell disease patients sampled in different regions of the State of Minas Gerais. The three-letters abbreviations are used hereafter for the different localities. 
